Where does Rhodes Technologies rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rhodes Technologies ranks #7,763 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rhodes Technologies hold?

Rhodes Technologies holds 42 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Rhodes Technologies's Innovation Score?

Rhodes Technologies has an Innovation Score of 38.7 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rhodes Technologies focus on?

Rhodes Technologies's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 40 patents, ranking #463 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Rhodes Technologies's patent grant rate increasing or decreasing?

Rhodes Technologies's recent grant velocity is -26% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rhodes Technologies's patents?

Rhodes Technologies's patents average 22.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rhodes Technologies patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rhodes Technologies

USPTO PatentsView assignee record - 42 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rhodes ranks #7,763 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 7 technology areas.

#7,763
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.7/100): 22.1
avg claims per patent: -26%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7763 · US Corporation #7,763 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 42 grants
UPPER-Q #7,763/49,997
PHOTO-FINISH Pioneer Pet Products
CPC-NARROW A61P · 7 areas
INNOV-THIN 38.7/100
CLAIMS-DENSE 22.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -26% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pioneer Pet Products, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rhodes’s 38.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (34%) Velocity 3.1 pts (8%) Breadth 9.4 pts (24%) Claim depth 13.2 pts (34%)

Qualcomm Incorporated · highest

85
Cardex Systems · near

39
Cour Pharmaceuticals… · near

39
Innovative Building · near

39
Rhodes · this assignee

39
Zendesk · near

39
3D Lighting… · lowest

7

What this shows Rhodes's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rhodes?

Each dot is one of Rhodes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rhodes’s own 22.1 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rhodes vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rhodes's grants concentrate

Rhodes Technologies is a focused PatentsView assignee: 7 CPC subclasses with 95.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2015. By volume, Rhodes sits between Pioneer Pet Products, LLC and Santec Holdings Corporation.

Rhodes's three-year grant acceleration

Rhodes Technologies shows 8 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pioneer Pet Produ…

42
Powdertech

42
Quality Electrody…

42
REC Solar PTE

42
Lhoist Recherche…

42
Safilo—SocietÀ Az…

42
Samsung Techwin

42
Santec Holdings

42
Rhodes ◀

42

What this shows Rhodes holds 42 patents at rank #7,762, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rhodes

By rank, the assignees closest to #7,762 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Rhodes's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rhodes, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Rhodes ranks #463 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Innovative Building Technologies, LLC 39 Zendesk, Inc. 39 Cardex Systems Inc. 39 Cour Pharmaceuticals Development Company Inc. 39

Rhodes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rhodes Technologies patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	4.8%
2016	5	11.9%
2017	5	11.9%
2018	3	7.1%
2019	8	19.0%
2020	6	14.3%
2021	3	7.1%
2022	2	4.8%
2023	4	9.5%
2024	2	4.8%
2025partial year	2	4.8%

Which technologies does Rhodes Technologies patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 40

C07D - Heterocyclic Compounds 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 26

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 8

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 5

C07C - Acyclic OR Carbocyclic Compounds 5

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rhodes Technologies's patent record in context - here's where to go next.

Rhodes Technologies's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 95.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,763 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rhodes Technologies against Pioneer Pet Products, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.